PSN-632,408: Difference between revisions
Appearance
Content deleted Content added
Updating {{drugbox}} (no changed fields - added verified revid - updated 'UNII_Ref', 'ChemSpiderID_Ref', 'StdInChI_Ref', 'StdInChIKey_Ref', 'ChEMBL_Ref', 'KEGG_Ref') per Chem/Drugbox validation ( |
removed Category:Pyridines; added Category:4-Pyridyl compounds using HotCat |
||
(11 intermediate revisions by 10 users not shown) | |||
Line 1: | Line 1: | ||
{{Short description|Chemical compound}} |
|||
{{Drugbox |
{{Drugbox |
||
| verifiedrevid = |
| verifiedrevid = 424766281 |
||
| IUPAC_name |
| IUPAC_name = ''tert''-butyl 4-[(3-pyridin-4-yl-1,2,4-oxadiazol-5-yl)methoxy]piperidine-1-carboxylate |
||
| image |
| image = PSN-632408-structure.png |
||
⚫ | |||
<!--Clinical data--> |
|||
⚫ | |||
| tradename = |
|||
| ATC_suffix = |
|||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
| molecular_weight = 360.407 g/mol |
|||
⚫ | |||
<!--Pharmacokinetic data--> |
|||
| bioavailability |
| bioavailability = |
||
| metabolism |
| metabolism = |
||
| elimination_half-life |
| elimination_half-life = |
||
| excretion |
| excretion = |
||
⚫ | |||
⚫ | |||
<!--Identifiers--> |
|||
⚫ | |||
| IUPHAR_ligand = 3319 |
|||
| CAS_number_Ref = {{cascite|correct|CAS}} |
|||
⚫ | |||
| UNII_Ref = {{fdacite|correct|FDA}} |
|||
| UNII = V4434XWK2P |
|||
⚫ | |||
⚫ | |||
| ChemSpiderID = 9637386 |
|||
| ChEMBL = 1081913 |
|||
<!--Chemical data--> |
|||
⚫ | |||
⚫ | |||
| StdInChI = 1S/C18H24N4O4/c1-18(2,3)25-17(23)22-10-6-14(7-11-22)24-12-15-20-16(21-26-15)13-4-8-19-9-5-13/h4-5,8-9,14H,6-7,10-12H2,1-3H3 |
|||
| StdInChIKey = LHZWKWCEAXQUMX-UHFFFAOYSA-N |
|||
}} |
}} |
||
'''PSN-632,408''' is a [[ |
'''PSN-632,408''' is a [[binding selectivity|selective]] [[ligand]] for the suggested novel [[cannabinoid receptor]] [[GPR119]].<ref name="pmid16517404">{{cite journal |vauthors = Overton HA, Babbs AJ, Doel SM, Fyfe MC, Gardner LS, Griffin G, Jackson HC, Procter MJ, Rasamison CM, Tang-Christensen M, Widdowson PS, Williams GM, Reynet C |title = Deorphanization of a G protein-coupled receptor for oleoylethanolamide and its use in the discovery of small-molecule hypophagic agents. | journal = Cell Metab. | volume = 3 | issue = 3 | pages = 167–175 | year = 2006 |pmid = 16517404 |doi = 10.1016/j.cmet.2006.02.004 | doi-access = free }}</ref> |
||
== See also == |
== See also == |
||
Line 26: | Line 42: | ||
== References == |
== References == |
||
{{Reflist |
{{Reflist}} |
||
{{Cannabinoids}} |
{{Cannabinoids}} |
||
⚫ | |||
⚫ | |||
⚫ | |||
[[Category:Oxadiazoles]] |
[[Category:Oxadiazoles]] |
||
[[Category:Piperidines]] |
[[Category:Piperidines]] |
||
[[Category:Carbamates]] |
[[Category:Carbamates]] |
||
[[Category:Tert-butyl compounds]] |
|||
⚫ |